We are live on !
Find out more
Klingman & Associates Portfolio holdings
AUM
$2.41B
Turnover
25.11%
1-Year Est. Return
15.13%
This Fund
S&P 500
This Quarter Est. Return
-0.01%
1 Year Est. Return
+15.13%
3 Year Est. Return
+64.93%
5 Year Est. Return
+60.65%
10 Year Est. Return
+171.45%
AUM
$2.41B
AUM Growth
+$56.5M
(+2.4%)
Cap. Flow
+$71.9M
Cap. Flow % of AUM
Cap. Flow %
2.99%
Top 10 Holdings %
Top 10 Hldgs %
52.74%
Holding
442
New
92
Increased
193
Reduced
85
Closed
19
Avg Time Held
3.5
years
Top 10 Avg Time Held
6.7
years
Top 20 Avg Time Held
5.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$11M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$5.76M |
| 3 |
Vanguard Core Tax-Exempt Bond ETF
VCRM
|
+$5.3M |
| 4 |
iShares iBonds Dec 2033 Term Corporate ETF
IBDY
|
+$4.5M |
| 5 |
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
|
+$3.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citizens Financial Group
CFG
|
+$12.8M |
| 2 |
JPMorgan Chase
JPM
|
+$2.17M |
| 3 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$2.02M |
| 4 |
Datadog
DDOG
|
+$1.52M |
| 5 |
iShares Short Maturity Bond ETF
NEAR
|
+$1.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.01% |
| 2 | Technology | 8.25% |
| 3 | Financials | 2.56% |
| 4 | Consumer Discretionary | 1.57% |
| 5 | Communication Services | 1.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.15B
| $1.71M | 0.07% |
13,496
+2,510
| +23% | +$337K |
2019 Q4
27 quarters
|
|
102
Coca-Cola
KO
$427B
| $1.69M | 0.07% |
19,619
+489
| +3% | +$42.4K |
2020 Q4
23 quarters
|
|
103
Walmart Inc
WMT
$1.02T
| $1.68M | 0.07% |
16,189
-1,277
| -7% | -$140K |
2020 Q3
24 quarters
|
|
104
United Bankshares
UBSI
$6.48B
| $1.63M | 0.07% |
35,398
| – | – |
2021 Q3
20 quarters
|
|
105
Deere & Co
DE
$182B
| $1.62M | 0.07% |
2,406
+33
| +1% | +$21K |
2020 Q4
23 quarters
|
|
106
Goldman Sachs
GS
$264B
| $1.61M | 0.07% |
1,790
+296
| +20% | +$303K |
2023 Q2
13 quarters
|
|
107
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$2.06B
| $1.58M | 0.07% |
28,103
-166
| -0.6% | -$10K |
2015 Q3
44 quarters
|
|
108
TSMC
TSM
$2.07T
| $1.57M | 0.07% |
3,450
+148
| +4% | +$62.7K |
2025 Q2
5 quarters
|
|
109
Merck
MRK
$364B
| $1.56M | 0.06% |
10,716
+253
| +2% | +$35K |
2014 Q4
47 quarters
|
|
110
Blackstone
BX
$95B
| $1.53M | 0.06% |
13,608
+20
| +0.1% | +$2.62K |
2019 Q3
28 quarters
|
|
111
Avantis US Large Cap Value ETF
AVLV
$23.5B
| $1.51M | 0.06% |
+16,722
| New | +$1.55M |
2026 Q3
0 quarters
|
|
112
Vanguard High Dividend Yield ETF
VYM
$83.9B
| $1.44M | 0.06% |
9,264
| – | – |
2014 Q4
47 quarters
|
|
113
iShares Russell Mid-Cap ETF
IWR
$58.7B
| $1.44M | 0.06% |
13,466
| – | – |
2014 Q4
47 quarters
|
|
114
Vanguard Morningstar Small-Cap Growth ETF
VBK
$22.3B
| $1.42M | 0.06% |
4,211
-213
| -5% | -$74.4K |
2019 Q4
27 quarters
|
|
115
NextEra Energy
NEE
$179B
| $1.37M | 0.06% |
18,119
-84
| -0.5% | -$7.1K |
2022 Q1
18 quarters
|
|
116
Abbott
ABT
$188B
| $1.36M | 0.06% |
13,790
+2,509
| +22% | +$262K |
2020 Q2
25 quarters
|
|
117
Lowe's Companies
LOW
$128B
| $1.36M | 0.06% |
7,365
+397
| +6% | +$82.4K |
2022 Q4
15 quarters
|
|
118
iShares MSCI Emerging Markets ETF
EEM
$28.2B
| $1.34M | 0.06% |
20,054
-300
| -1% | -$19.8K |
2017 Q4
35 quarters
|
|
119
Bank of America
BAC
$352B
| $1.32M | 0.05% |
24,162
+4,596
| +23% | +$280K |
2020 Q4
23 quarters
|
|
120
Thermo Fisher Scientific
TMO
$259B
| $1.31M | 0.05% |
1,940
+44
| +2% | +$26.1K |
2022 Q4
15 quarters
|
|
121
Schwab International Equity ETF
SCHF
$67.8B
| $1.29M | 0.05% |
47,052
| – | – |
2019 Q4
27 quarters
|
|
122
Philip Morris
PM
$310B
| $1.28M | 0.05% |
6,725
+171
| +3% | +$32.3K |
2023 Q2
13 quarters
|
|
123
State Street Technology Select Sector SPDR ETF
XLK
$114B
| $1.27M | 0.05% |
6,474
-56
| -0.9% | -$10.3K |
2019 Q2
29 quarters
|
|
124
Morgan Stanley
MS
$298B
| $1.26M | 0.05% |
6,685
+615
| +10% | +$131K |
2024 Q1
10 quarters
|
|
125
Pfizer
PFE
$165B
| $1.25M | 0.05% |
43,749
+15,512
| +55% | +$413K |
2025 Q1
6 quarters
|
|
Similar funds
Klingman & Associates's Q3 2026 Portfolio in Review
As of Q3 2026, Klingman & Associates held 442 positions worth $2.41B, up 2.4% from $2.35B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Klingman & Associates's Q3 2026 filing shows 92 new, 193 increased, 85 reduced and 19 closed positions. Its largest new stake was Vanguard Core Tax-Exempt Bond ETF: 71,106 shares worth $5.09M. The largest sale was Citizens Financial Group, an estimated $12.8M.
By sector, the portfolio is most concentrated in Miscellaneous at 82% of assets, down from 83% a quarter earlier, followed by Technology and Financials.
- Klingman & Associates's largest Q3 2026 buy was Vanguard Core Tax-Exempt Bond ETF: 71,106 shares worth $5.09M.
- Klingman & Associates added most to Vanguard Short-Term Inflation-Protected Securities Index Fund in Q3 2026, an estimated $11M increase.
- Klingman & Associates's biggest Q3 2026 reduction was Citizens Financial Group, cutting an estimated $12.8M.
- Klingman & Associates fully exited iShares Short Maturity Bond ETF in Q3 2026, selling an estimated $1.3M.
- Klingman & Associates's ten largest holdings make up 53% of its $2.41B portfolio in Q3 2026.
- Klingman & Associates opened 92 new positions and closed 19 in Q3 2026.
- Klingman & Associates's portfolio value rose 2.4% quarter-over-quarter to $2.41B.
Based on Klingman & Associates's 13F filing for Q3 2026, filed 20 Oct 2026.